$2.50
-0.13-4.94%
At Close: -
$2.58
0.083.20%
After Hours: 7:52 PM EDT
15 minutes delayed
AN2 Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AN2 Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ANTX | AN2 Therapeutics | -$0.81 | -$0.59 | — | — | $0.00 | — | — | — | 08/08/2024 | Get Alert |
ANTX | AN2 Therapeutics | -$0.79 | -$0.62 | -$0.56 | 9.68% | $0.00 | — | $0.00 | — | 05/14/2024 | Get Alert |
ANTX | AN2 Therapeutics | -$0.61 | -$0.76 | -$0.57 | 25.00% | $0.00 | — | $0.00 | — | 03/28/2024 | Get Alert |
ANTX | AN2 Therapeutics | -$0.59 | -$0.70 | -$0.65 | 7.14% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
ANTX | AN2 Therapeutics | -$0.53 | -$0.85 | -$0.81 | 4.71% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
ANTX | AN2 Therapeutics | -$2.98 | -$0.68 | -$0.79 | -16.18% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
ANTX | AN2 Therapeutics | -$3.57 | -$0.65 | -$0.61 | 6.15% | $0.00 | — | $0.00 | — | 03/29/2023 | Get Alert |
ANTX | AN2 Therapeutics | -$3.35 | -$0.59 | -$0.59 | 0.00% | — | — | $0.00 | — | 11/09/2022 | Get Alert |
ANTX | AN2 Therapeutics | -$2.62 | -$0.46 | -$0.53 | -15.22% | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
ANTX | AN2 Therapeutics | -$1.07 | — | -$2.98 | — | $0.00 | — | $0.00 | — | 05/10/2022 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-14 | $-0.56 | $-0.62 | 9.68 % |
Dec 2023 | 2024-03-28 | $-0.57 | $-0.76 | 25.0 % |
Sep 2023 | 2023-11-09 | $-0.65 | $-0.70 | 7.14 % |
Jun 2023 | 2023-08-10 | $-0.81 | $-0.85 | 4.71 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
AN2 Therapeutics (ANTX) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
The Actual EPS was $-0.56, which beat the estimate of $-0.62.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.